A 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical Prostatectomy

por Marrone, Michael, Potosky, Arnold L., Penson, David, Freedman, Andrew N.
Publicado 2015

Obesity, body composition, and prostate cancer

por Fowke, Jay H, Motley, Saundra S, Concepcion, Raoul S, Penson, David F, Barocas, Daniel A
Publicado 2012

Osteoclast inhibitor treatment among men with metastatic castration-resistant prostate cancer

por Sonnenburg, Daniel, Chaudhuri, Parul, Graves, Amy J., Penson, David F., Morgans, Alicia K.
Publicado 2018

Fibromyxoid Nephrogenic Adenoma in the Ureter

por Dropkin, Benjamin M., Giannico, Giovanna A., Reisz, Peter A., Penson, David F., Hsi, Ryan S.
Publicado 2018

Checklist to operationalize measurement characteristics of patient-reported outcome measures

por Francis, David O., McPheeters, Melissa L., Noud, Meaghan, Penson, David F., Feurer, Irene D.
Publicado 2016

COVID-19 and financial toxicity in patients with renal cell carcinoma

por Staehler, Michael D., Battle, Dena J., Bergerot, Cristiane D., Pal, Sumanta Kumar, Penson, David F.
Publicado 2020

Patient expectations of benefit from systemic treatments for metastatic prostate cancer

por Oswald, Laura B., Kasimer, Rachel, Rappazzo, Katherine, Fought, Angela J., Penson, David F., Morgans, Alicia K.
Publicado 2019

What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study

por Oswald, Laura B, Schumacher, Frank A, Gonzalez, Brian D, Moses, Kelvin A, Penson, David F, Morgans, Alicia K
Publicado 2020

Health System Perspective on Cost for Delivering a Decision Aid for Prostate Cancer Using Time-driven Activity-based Costing

por Ho, David R., Kaplan, Robert, Bergman, Jonathan, Penson, David F., Waterman, Benjamin, Williams, Kristen C., Villatoro, Jefersson, Kwan, Lorna, Saigal, Christopher S.
Publicado 2023

Surgeons’ Perspective of Decision Making in Recurrent Diverticulitis: A Qualitative Analysis

por Hawkins, Alexander T., Rothman, Russell L., Geiger, Timothy M., Bonnet, Kemberlee R., Mutch, Matthew G., Regenbogen, Scott E., Schlundt, David G., Penson, David F.
Publicado 2022

Successful external validation of a model to predict other cause mortality in localized prostate cancer

por Kent, Matthew, Penson, David F., Albertsen, Peter C., Goodman, Michael, Hamilton, Ann S., Stanford, Janet L., Stroup, Antoinette M., Ehdaie, Behfar, Scardino, Peter T., Vickers, Andrew J.
Publicado 2016

Bone Complications Among Prostate Cancer Survivors: Long-Term Follow-Up From the Prostate Cancer Outcomes Study

por Morgans, Alicia K., Fan, Kang-Hsien, Koyama, Tatsuki, Albertsen, Peter C., Goodman, Michael, Hamilton, Ann S., Hoffman, Richard M., Stanford, Janet L., Stroup, Antoinette M., Penson, David F.
Publicado 2014

Treatment registry for outcomes in patients with castration-resistant prostate cancer (TRUMPET): a methodology for real-world evidence and research

por Penson, David F, Lin, Daniel W, Karsh, Lawrence, Quinn, David I, Shevrin, Daniel H, Shore, Neal, Symanowski, James T, Brown, Bruce, Forer, David, Wong, Elaine K, Flanders, Scott C
Publicado 2016

Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

por Schultz, Neil M., Shore, Neal D., Chowdhury, Simon, Klotz, Laurence H., Concepcion, Raoul S., Penson, David F., Karsh, Lawrence I., Yang, Hongbo, Brown, Bruce A., Barlev, Arie, Flanders, Scott C.
Publicado 2018

Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials

por Schultz, Neil M, Shore, Neal D, Chowdhury, Simon, Klotz, Laurence H, Concepcion, Raoul S, Penson, David F, Karsh, Lawrence I, Yang, Hongbo, Brown, Bruce A, Barlev, Arie, Flanders, Scott C
Publicado 2018

Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial

por Penson, David F., Armstrong, Andrew J., Concepcion, Raoul S., Agarwal, Neeraj, Olsson, Carl A., Karsh, Lawrence I., Dunshee, Curtis J., Duggan, William, Shen, Qi, Sugg, Jennifer, Haas, Gabriel P., Higano, Celestia S.
Publicado 2021

Correction: Enzalutamide versus bicalutamide in patients with nonmetastatic castration-resistant prostate cancer: a prespecified subgroup analysis of the STRIVE trial

por Penson, David F., Armstrong, Andrew J., Concepcion, Raoul S., Agarwal, Neeraj, Olsson, Carl A., Karsh, Lawrence I., Dunshee, Curtis J., Duggan, William, Shen, Qi, Sugg, Jennifer, Haas, Gabriel P., Higano, Celestia S.
Publicado 2021

A randomized trial of a specialist palliative care intervention for patients undergoing surgery for cancer: rationale and design of the Surgery for Cancer with Option of Palliative...

por Shinall, Myrick C., Hoskins, Aimee, Hawkins, Alexander T., Bailey, Christina, Brown, Alaina, Agarwal, Rajiv, Duggan, Maria C., Beskow, Laura M., Periyakoil, Vyjeyanthi S., Penson, David F., Jarrett, Ryan T., Chandrasekhar, Rameela, Ely, E. Wesley
Publicado 2019

Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study...

por Rim, Sun Hee, Hall, Ingrid J, Fairweather, Megan E, Fedorenko, Catherine R, Ekwueme, Donatus U, Smith, Judith Lee, Thompson, Ian M, Keane, Thomas E, Penson, David F, Moinpour, Carol M, Zeliadt, Steven B, Ramsey, Scott D
Publicado 2011

The Association Between Financial Toxicity and Treatment Regret in Men With Localized Prostate Cancer

por Joyce, Daniel D, Wallis, Christopher J D, Huang, Li-Ching, Hoffman, Karen E, Zhao, Zhiguo, Koyama, Tatsuki, Goodman, Michael, Hamilton, Ann S, Wu, Xiao-Cheng, Paddock, Lisa E, Stroup, Antoinette, Cooperberg, Matthew R, Hashibe, Mia, O’Neil, Brock B, Kaplan, Sherrie H, Greenfield, Sheldon, Penson, David F, Barocas, Daniel A
Publicado 2022